Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies: Part II: clinical protocol
- 31 October 2002
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 12, S45-S48
- https://doi.org/10.1016/s0960-8966(02)00081-0
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophyGene Therapy, 2000
- Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx miceGene Therapy, 2000
- The clinical, genetic and dystrophin characteristics of Becker muscular dystrophyZeitschrift für Neurologie, 1993
- Genotype/phenotype correlations in Duchenne/Becker dystrophyPublished by Springer Nature ,1993